Literature DB >> 25972627

Synchronous primary malignancies in breast and kidney: a rare case report.

U A Kurlekar1, A S Rayate2.   

Abstract

Multiple synchronous malignancies are rarer than metachronous ones. Primary synchronous breast and renal cancer is even rare. Such a case requires strict exclusion of possible metastasis to either site and to confirm the primary nature of each malignancy for better outcome of management and survival benefit. Multiple primary synchronous malignancies may be due to shared genetic mutations if any common carcinogenic factor cannot be found. The role of estrogens in cases in which human renal carcinoma is associated with other primary tumours involving steroid-hormone target tissues, is tentative and can only be hypothesised due to paucity of such data in literature. One should consider the possibility of concomitant dual or multiple primary tumours in a patient presented with mass lesions at various sites, especially if one of the sites is the kidney. We present a case report of a patient with synchronous primary breast and renal cancer.

Entities:  

Keywords:  Breast carcinoma; Multiple; Primary; Renal carcinoma; Synchronous

Year:  2014        PMID: 25972627      PMCID: PMC4425711          DOI: 10.1007/s12262-013-1031-0

Source DB:  PubMed          Journal:  Indian J Surg        ISSN: 0973-9793            Impact factor:   0.656


  6 in total

1.  Multiple primary tumors: 17 cases of renal-cell carcinoma associated with primary tumors involving different steroid-hormone target tissues.

Authors:  F Di Silverio; A Sciarra; G P Flammia; M Mariani; A De Vico
Journal:  World J Urol       Date:  1997       Impact factor: 4.226

2.  Cancer statistics, trends, and multiple primary cancer analyses from the Surveillance, Epidemiology, and End Results (SEER) Program.

Authors:  Matthew J Hayat; Nadia Howlader; Marsha E Reichman; Brenda K Edwards
Journal:  Oncologist       Date:  2007-01

3.  Multiple primary malignancies in patients with renal cell carcinoma: a national population-based cohort study.

Authors:  Christian Beisland; Olaug Talleraas; August Bakke; Jarle Norstein
Journal:  BJU Int       Date:  2006-04       Impact factor: 5.588

4.  Second primary malignancies associated with renal cell carcinoma: influence of histologic type.

Authors:  F Rabbani; V E Reuter; J Katz; P Russo
Journal:  Urology       Date:  2000-09-01       Impact factor: 2.649

5.  Multiple primary malignancies in renal cell carcinoma.

Authors:  F Rabbani; G Grimaldi; P Russo
Journal:  J Urol       Date:  1998-10       Impact factor: 7.450

6.  Occasional diagnosis of synchronous renal cell carcinoma during staging of other primary tumors.

Authors:  L Piccinini; G Luppi; A Zoboli; P Torricelli
Journal:  Tumori       Date:  1996 Sep-Oct
  6 in total
  5 in total

1.  Breast Cancer with Synchronous Renal Cell Carcinoma: A Rare Presentation.

Authors:  Ravi Arjunan; Durgesh Kumar; K V Veerendra Kumar; C S Premlatha
Journal:  J Clin Diagn Res       Date:  2016-10-01

2.  Studying the association between breast cancer and renal cell carcinoma.

Authors:  Khalid Jazieh; Firas Baidoun; Nataly Torrejon; Zahi Merjaneh; Anas Saad; Mohamed Gad; Amal Farouk; Moshe Ornstein; Jame Abraham
Journal:  Breast Cancer Res Treat       Date:  2021-12-02       Impact factor: 4.872

3.  An exceedingly rare simultaneous incidental occurrence of synchronous primary malignancies; Invasive Ductal Carcinoma and Renal Cell Carcinoma in a male - A Case Report.

Authors:  Omar Al Laham; Fareed Atia; Dana Ibrahim; Jack Shaheen; Bashir Hokouk
Journal:  Int J Surg Case Rep       Date:  2022-06-30

4.  Co-existent breast and renal cancer.

Authors:  Orhan Üreyen; Emrah Dadalı; Fırat Akdeniz; Tamer Şahin; Mehmet Tahsin Tekeli; Nuket Eliyatkın; Hakan Postacı; Enver İlhan
Journal:  Ulus Cerrahi Derg       Date:  2015-07-10

5.  Synchronous breast invasive ductal carcinoma and clear cell renal carcinoma: case report and a review of literature.

Authors:  Amr Elgazar; Ahmed K Awad; Debvarsha Mnadal; Merihan A Elbadawy; Sheref A Elseidy
Journal:  J Surg Case Rep       Date:  2021-07-19
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.